Client News

Affluent Medical Announces the Availability of a Prospectus for the Admission to Trading of 6,190,831 Shares Issued as Part of a Capital Increase without Preferential Subscription Rights in Favour of a Category of Beneficiaries

Affluent Medical Signs Agreements for Mitral Valve Technologies with EUR 15M Upfront Payment

Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational

HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test

Andera Partners Co-Leads a €63 Million Series A Round for Munich-Based Autoimmune Biotech SciRhom

MIG Capital Co-Leads €63 Million Series A Round for Autoimmune Biotech SciRhom

APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China